statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Bitcoin

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Invesco QQQ Trust Series 1

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Analyst Scoreboard: 4 Ratings For Akoya Biosciences

Latest Ratings for AKYA
 DateFirmActionFromTo Feb 2022Morgan StanleyMaintainsOverweight May 2021Canaccord GenuityInitiates Coverage OnBuy May 2021JP MorganInitiates Coverage OnOverweight
 View...

Akoya Biosciences Showcases Spatial Biology 2.0 Solutions at AACR Annual Meeting with Case Studies Demonstrating Unprecedented Speed and Scale

MARLBOROUGH, Mass., April 05, 2024 (GLOBE NEWSWIRE) -- Akoya Biosciences, Inc., (Nasdaq: AKYA), The Spatial Biology Company , today announced it will highlight case studies featuring its Spatial...

Akoya BioSciences (AKYA, $4.63) entered Downtrend as Momentum indicator drops below 0 level on Mar 26, 2024

This indicator may be signaling that AKYA's price has further to drop, since it moved below its price 14 days ago. Traders may consider selling the stock, shorting the stock, or exploring put options...

Akoya BioSciences (AKYA, $4.79) entered Downtrend as Momentum indicator drops below 0 level on Mar 22, 2024

Akoya BioSciences (AKYA, $5.05) entered Uptrend as Momentum indicator ascends above 0 level on Mar 20, 2024

This indicator may be signaling AKYA's price has momentum to move higher, since its current price moved above its price 14 days ago. Traders may consider buying the stock or exploring call options...

Akoya BioSciences (AKYA, $5.1) entered Downtrend as Momentum indicator drops below 0 level on Mar 05, 2024

Akoya Biosciences Inc (AKYA) Reports Record Q4 Revenue and Sets Positive 2024 Outlook

Company Eyes Operating Cash Flow Breakeven by Year-End 2024Related Stocks: AKYA...

Akoya Biosciences sees operating cash flow breakeven by year end

See the rest of the story here.

thefly.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fly's real-time, streaming news feed keeps individual...

Akoya Biosciences reports Q4 EPS (22c), consensus (28c)

Recap: Akoya Biosciences Q4 Earnings

Akoya Biosciences, Inc. is a life sciences technology company delivering spatial biology solutions focused on transforming discovery and clinical research. The company offers comprehensive single-cell imaging solutions that allow researchers to phenotype cells with spatial context and visualize how they organize and interact to influence disease progression and treatment response. Akoya offers two distinct solutions, the CODEX and Phenoptics platforms, to serve the diverse needs of researchers across discovery, translational and clinical research. The company was founded by Garry Nolan, Yury Goltsev and Nikolay Samusik in 2015 and is headquartered in Marlborough, MA.

Akoya Biosciences Inc

Volume	104,409.00
52-Wk High	$7.06
52-Wk Low	$1.88

AKYA Akoya Biosciences Inc

About

Feed

News

Sentiment

Earnings

Fundamentals